BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 32925168)

  • 41. Natural killer cell recognition of missing self.
    Kärre K
    Nat Immunol; 2008 May; 9(5):477-80. PubMed ID: 18425103
    [No Abstract]   [Full Text] [Related]  

  • 42. Natural killer cells, viruses and cancer.
    Cerwenka A; Lanier LL
    Nat Rev Immunol; 2001 Oct; 1(1):41-9. PubMed ID: 11905813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natural killer cells: their roles in defenses against disease.
    Herberman RB; Ortaldo JR
    Science; 1981 Oct; 214(4516):24-30. PubMed ID: 7025208
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell.
    Kiessling R; Klein E; Pross H; Wigzell H
    Eur J Immunol; 1975 Feb; 5(2):117-21. PubMed ID: 1086218
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NK Cell Metabolism and Tumor Microenvironment.
    Terrén I; Orrantia A; Vitallé J; Zenarruzabeitia O; Borrego F
    Front Immunol; 2019; 10():2278. PubMed ID: 31616440
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of cytokines in the regulation of NK cells in the tumor environment.
    Konjević GM; Vuletić AM; Mirjačić Martinović KM; Larsen AK; Jurišić VB
    Cytokine; 2019 May; 117():30-40. PubMed ID: 30784898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor Microenvironment-Associated Extracellular Matrix Components Regulate NK Cell Function.
    Rossi GR; Trindade ES; Souza-Fonseca-Guimaraes F
    Front Immunol; 2020; 11():73. PubMed ID: 32063906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional and metabolic targeting of natural killer cells to solid tumors.
    Wang J; Matosevic S
    Cell Oncol (Dordr); 2020 Aug; 43(4):577-600. PubMed ID: 32488848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy?
    Ben-Shmuel A; Biber G; Barda-Saad M
    Front Immunol; 2020; 11():275. PubMed ID: 32153582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NK cell-based therapeutics for lung cancer.
    Pockley AG; Vaupel P; Multhoff G
    Expert Opin Biol Ther; 2020 Jan; 20(1):23-33. PubMed ID: 31714156
    [No Abstract]   [Full Text] [Related]  

  • 51. Mechanism of tumor cells escaping from immune surveillance of NK cells.
    Ge Z; Wu S; Zhang Z; Ding S
    Immunopharmacol Immunotoxicol; 2020 Jun; 42(3):187-198. PubMed ID: 32223464
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
    Gaggero S; Witt K; Carlsten M; Mitra S
    Front Immunol; 2020; 11():621225. PubMed ID: 33584718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors.
    Melaiu O; Lucarini V; Cifaldi L; Fruci D
    Front Immunol; 2019; 10():3038. PubMed ID: 32038612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Checkpoint Inhibitors and Engineered Cells: New Weapons for Natural Killer Cell Arsenal Against Hematological Malignancies.
    Giuliani M; Poggi A
    Cells; 2020 Jun; 9(7):. PubMed ID: 32610578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural Killer Cells and Dendritic Cells: Expanding Clinical Relevance in the Non-Small Cell Lung Cancer (NSCLC) Tumor Microenvironment.
    Ahluwalia P; Ahluwalia M; Mondal AK; Sahajpal NS; Kota V; Rojiani MV; Kolhe R
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Landscape of natural killer cell activity in head and neck squamous cell carcinoma.
    Charap AJ; Enokida T; Brody R; Sfakianos J; Miles B; Bhardwaj N; Horowitz A
    J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33428584
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NK cells in the tumor microenvironment and thioredoxin activity.
    Whiteside TL
    J Clin Invest; 2020 Oct; 130(10):5115-5117. PubMed ID: 32925168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Harnessing Natural Killer Cells in Non-Small Cell Lung Cancer.
    Russell É; Conroy MJ; Barr MP
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203256
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.